Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Aicardi syndrome is a rare neurodevelopmental disorder defined by the triad of agenesis of the corpus callosum (total or partial), typical chorioretinal lacunae and infantile spasms that affect almost exclusively females.
Features include very common findings: Infantile spasms, Partial agenesis of the corpus callosum, Pachygyria, and Polymicrogyria and others; and common findings: Low muscle tone (hypotonia), Block vertebrae, Microcephaly, and Prominence of the premaxilla and others. 79 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 10 | Seizure, Profound intellectual disability, Epileptic spasm |
No consensus clinical diagnostic criteria for Aicardi syndrome have been published. The diagnosis of Aicardi syndrome is based exclusively on clinical findings. Modified diagnostic criteria have been proposed [, adapted from ]:
The presence of the classic triad is diagnostic for Aicardi syndrome.
The presence of two of the classic triad plus at least two other major or supporting features is strongly suggestive of the diagnosis of Aicardi syndrome.
No approved treatments are currently available for Aicardi syndrome. The disease remains an area of unmet medical need.
No clinical practice guidelines for Aicardi syndrome have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with Aicardi syndrome, the evaluations summarized (if not performed as part of the evaluation that led to diagnosis) are recommended. Table 3. Recommended Evaluations Following Initial Diagnosis in Individuals with Aicardi Syndrome
Table 5.
Recommended Surveillance for Individuals with Aicardi Syndrome
System/Concern | Evaluation | Frequency
| • Measure growth parameters.
Evaluate nutritional status safety of oral intake.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
132 publications have been identified in PubMed for Aicardi syndrome. Research spans Basic Science / Preclinical (33%), Case Report / Case Series (23%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 44 | 33% |
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Aicardi syndrome
Eyes | 6 | Cataract, Nystagmus, Damage to the optic nerve (optic atrophy) |
Digestive system | 6 | Hepatoblastoma, Constipation, Gastroesophageal reflux |
Head and neck | 4 | Cleft palate, Microcephaly, Cleft upper lip |
Muscles | 3 | Low muscle tone (hypotonia), Generalized hypotonia, Damage to the optic nerve (optic atrophy) |
Skin | 3 | Skin tags, Abnormality of the skin, Skin color changes (abnormality of skin pigmentation) |
Bones and joints | 3 | Block vertebrae, Butterfly vertebrae, Sideways curvature of the spine (scoliosis) |
Hormones | 2 | Precocious puberty, Delayed puberty |
Growth and development | 1 | Postnatal growth retardation |
Lungs and breathing | 1 | Recurrent pneumonia |
Arms and legs | 1 | Small hand |
Aicardi syndrome, first described by , is a neurodevelopmental disorder that affects primarily females . Initially it was characterized by a typical triad of agenesis of the corpus callosum, typical chorioretinal lacunae, and infantile spasms; however, as more affected individuals have been ascertained, it has become clear that other neurologic and systemic defects are common. Indeed, not all affected girls have all three features of the classic triad . Table 1. Select Features of Aicardi Syndrome
Feature | % of Personsw/Feature | Comment |
|---|---|---|
Neurologic | Seizures | 95% |
ID/DD | 100% | Many have severe-profound ID do not develop language or ability to walk or sit independently; however, the degree of developmental impairment varies. |
Structural brainmalformations | 100% | While agenesis of the corpus callosum is part of the classic triad, virtually all have other brain malformations (e.g., heterotopias, cysts). |
Ocular | Chorioretinallacunae | 100% |
Optic nerveabnormalities | 90% | Colobomas hypoplasia of optic nerves are common visual impairment. |
Other | Costovertebralabnormalities | ~50% |
Source: GeneReviews — "Aicardi Syndrome"
Agenesis of the corpus callosum
Distinctive chorioretinal lacunae
Infantile spasms
Major features
Cortical malformations (mostly polymicrogyria)
Periventricular and subcortical heterotopia
Cysts around third cerebral ventricle and/or choroid plexus
Optic disc/nerve coloboma or hypoplasia
Supporting features
Source: GeneReviews — "Aicardi Syndrome"
Agenesis of the corpus callosum may occur in isolation, in conjunction with other brain malformations, or as part of a larger syndrome. It has been suggested that agenesis of the corpus callosum in association with cysts that do not communicate with the ventricles and presence of subependymal heterotopia and polymicrogyria is relatively specific for Aicardi syndrome . Neuronal migration disorders, including polymicrogyria, pachygyria, and heterotopia, may occur as isolated malformations or as part of the phenotype associated with other syndromes or chromosome abnormalities. Infantile spasms are observed in most girls with Aicardi syndrome, but this type of seizure is not specific for Aicardi syndrome. Infantile spasms may occur in isolation or as part of the phenotype of other syndromes, inborn errors of metabolism, or chromosome disorders. Hereditary disorders. See . Table 2. Genes of Interest in the Differential Diagnosis of Aicardi Syndrome
Gene(s) | DiffDx Disorder | MOI | Features of DiffDx Disorder |
|---|---|---|---|
Neurologic | Ophthalmologic | Other | Distinguishing from AIC COX7B HCCS NDUFB11 |
Microphthalmia w/linear skin defects syndrome | XL | Corpus callosum agenesis, seizures, ID | Microphthalmia, cataract, coloboma |
X-linked periventricular heterotopia | XL | Neuronal migration defects, seizures, ID | None |
KIF11 | MCLMR (OMIM 152950) | AD | Severe microcephaly, ID |
PLK4 | MCCRP2 (OMIM 616171) | AR | Severe microcephaly, ID |
PORCN | Focal dermal hypoplasia (Goltz syndrome) | XL | Normal ID |
Tuberous sclerosis complex | AD | Infantile spasms, cortical tubers | Achromic retinal patches |
TUBGCP4 | MCCRP3 (OMIM 616335) | AR | Severe microcephaly, ID |
TUBGCP6 | MCCRP1 (OMIM 251270) | AR | Severe microcephaly, ID |
Source: GeneReviews — "Aicardi Syndrome"
Biomarker and diagnostic research for Aicardi syndrome has been reported in the published literature.
System/Concern | Evaluation | Comment |
|---|---|---|
Constitutional | Measure height, weight, head circumference. | — |
Neurologic | Neurologic eval | To incl brain MRI; Consider EEG if seizures are a concern. |
Development | Developmental assessment | To incl motor, adaptive, cognitive, speech-language eval; Eval for early intervention/ special education Psychiatric/ |
Behavioral | Neuropsychiatric eval | For persons age 12 mos: screening for concerns incl sleep disturbances, ADHD, anxiety, /or findings suggestive of ASD Costovertebral |
abnormalities | Spine radiographs | To evaluate for hemivertebrae, block vertebrae, fused vertebrae; missing, malformed, fused ribs; Orthopedics consultation if costovertebral abnormalities are significant Musculoskeletal / |
Activities of daily living | Physical medicine rehab / PT OT eval | To incl assessment of:; Gross motor fine motor skills; Mobility, activities of daily living, need for adaptive devices; Need for PT (to improve gross motor skills) /or OT (to improve fine motor skills) Gastrointestinal/ |
Feeding | Gastroenterology/nutrition/feeding team eval | To incl:; History of constipation, diarrhea, GERD; Eval of aspiration risk nutritional status; Consider eval for gastrostomy tube placement in affected persons w/dysphagia /or aspiration risk. |
Eyes/Vision | Ophthalmologic eval | To assess for vision, abnormal ocular movement, strabismus |
Endocrine | Physical exam for evidence of precocious or delayed puberty | — |
Skin | Dermatologic eval | For vascular malformations pigmentary lesions at risk for malignant transformation Risk of |
malignancy | No regular screening recommended, given variety of tumors seen. Treating clinicians should be alert to risk of malignancy. | Angiosarcoma, hepatoblastoma, medulloblastoma, embryonal carcinoma, teratoma have been reported. Genetic |
counseling | By genetics professionals1 | To date, no gene has been identified as causative of Aicardi syndrome. Genetic testing may be warranted to rule out , esp if presentation is not classic for Aicardi syndrome. Family support resources |
Treatment of Manifestations in Individuals with Aicardi Syndrome Manifestation/Concern | Treatment | Considerations/Other |
Developmental delay / Intellectual disability | See . | — |
Epilepsy | Standardized treatment w/ASM by experienced neurologist; recent studies have shown ≤50% in median number of seizures w/cannabidiol.1 | Most persons require multiple medications for mgmt of seizures, seizure types may change over time, requiring changes in medications.; Education of parents/caregivers2 Poor weight gain / |
Failure to thrive | Feeding therapy; gastrostomy tube placement may be required for persistent feeding issues. | Low threshold for clinical feeding eval /or radiographic swallowing study if clinical signs or symptoms of dysphagia Mobility / Activities |
of daily living | Orthopedics/ physical medicine rehab/ PT OT incl stretching to help avoid contractures falls | Consider need for positioning mobility devices, hygiene, disability parking placard. Abnormal vision |
/or strabismus | Standard treatment(s) as recommended by ophthalmologist | Community vision services through early intervention or school district |
Costovertebral abnormalities | Per treating orthopedist | Can incl musculoskeletal support treatment for prevention of scoliosis-related complications |
Bowel dysfunction | Monitor for constipation. | Stool softeners, prokinetics, osmotic agents, or laxatives as needed ASM = anti-seizure medication; OT = occupational therapy; PT = physical therapy 1. 2. Education of parents/caregivers regarding common seizure presentations is appropriate. |
Source: GeneReviews — "Aicardi Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Aicardi Syndrome"
1 trial found
| At each visit
| Monitor for constipation other bowel problems; stool softeners or pro-motility agents as needed.
| Monitor for evidence of aspiration, respiratory insufficiency.
| • Monitor those w/seizures as clinically indicated.
Assess for new manifestations incl seizures, changes in tone (e.g., spasticity), movement disorders.
| Monitor developmental progress educational needs.
Psychiatric/
| Behavioral assessment for anxiety, attention, aggressive or self-injurious behavior
| Physical medicine, OT/PT assessment of mobility, self-help skills
Costovertebral
abnormalities | Monitor spine for progression of scoliosis (by exam; perform radiographs as needed).
Precocious or
delayed puberty | Pediatric endocrinologist w/hormonal testing supplementation as needed | If symptomatic
| Treating physicians should be aware of possible risk of rare malignancies; if there are symptoms concerning for a malignancy, consider screening.
Family /
| Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources) care coordination. | At each visit
OT = occupational therapy; PT = physical therapy
Source: GeneReviews — "Aicardi Syndrome"
Phenotype severity distribution: 9 very common features, 20 common features.
Estimated prevalence: 1-9 in 1,000,000 (Rare).
Patient case studies |
30 |
23% |
Disease patterns and progression | 21 | 16% |
Research summaries | 20 | 15% |
Clinical study results | 6 | 5% |
New treatment approaches | 5 | 4% |
Other research | 3 | 2% |
Testing and diagnosis research | 3 | 2% |
Sevagamoorthy A (2026). [PMID: 41671914](https://pubmed.ncbi.nlm.nih.gov/41671914/). *Mol Genet Metab*. [Clinical Trial Publication]
Marinella G (2026). [PMID: 41871482](https://pubmed.ncbi.nlm.nih.gov/41871482/). *Mol Genet Metab*. [Epidemiology / Natural History]
Tsujioka Y (2026). [PMID: 42176059](https://pubmed.ncbi.nlm.nih.gov/42176059/). *Pediatr Radiol*. [Review / Meta-Analysis]
Batignes M (2026). [PMID: 41776196](https://pubmed.ncbi.nlm.nih.gov/41776196/). *Nat Commun*. [Basic Science / Preclinical]
Le A (2026). [PMID: 41518854](https://pubmed.ncbi.nlm.nih.gov/41518854/). *Pediatr Neurol*. [Other]
Singh A (2026). [PMID: 41242038](https://pubmed.ncbi.nlm.nih.gov/41242038/). *Bioorganic & medicinal chemistry*. [Basic Science / Preclinical]
Spivak I (2026). [PMID: 41530961](https://pubmed.ncbi.nlm.nih.gov/41530961/). *Lupus*. [Epidemiology / Natural History]
Winata CA (2026). [PMID: 41241047](https://pubmed.ncbi.nlm.nih.gov/41241047/). *Exp Neurol*. [Basic Science / Preclinical]
Calame DG (2026). [PMID: 41959779](https://pubmed.ncbi.nlm.nih.gov/41959779/). *medRxiv*. [Basic Science / Preclinical]
Hosseini SA (2026). [PMID: 31335009](https://pubmed.ncbi.nlm.nih.gov/31335009/). *Unknown Journal*. [Basic Science / Preclinical]